Genedrive Share Discussion Threads

[theaviator] 25/6/2021 11:26

Never seen the likes. Crazy.

[babbler] 25/6/2021 11:25

They are slow with rns for sure.

[theaviator] 25/6/2021 11:22

Just trying to find what kind of quantities they can do

[theaviator] 25/6/2021 11:12

Jeez Louise. Multibagger

[smackeraim] 25/6/2021 11:12

https://health.economictimes.indiatimes.com/news/diagnostics/cdsco-provides-import-license-for-genedrive-covid-testing-kits-to-divoc-health/83836963

[theaviator] 25/6/2021 11:10

Daily seems to have plenty of juice left

[theaviator] 25/6/2021 11:09

What's the news Babs?

[babbler] 25/6/2021 11:08

Advfn live price stuck as usual.

[david gruen] 25/6/2021 10:51

"Peaky0025 Jun '21 - 01:15 - 6493 of 6502

Peaky always said this was heading to 20p range when this was 1.50ish.... remember"

Yes, we remember.

[david gruen] 25/6/2021 10:43

All time highs imminent.

[g2theary] 25/6/2021 10:40

100p today :D

[robinyou] 25/6/2021 10:39

GDR!!!!!!
Game changing news.
Can't buy in great size now.
Back to a pound when the official RNS gets released.

DIVOC Health receives import license for covid testing kits from CDSCO
25 June 2021 | News



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients

Image crdit: hxxps://divoc.health/
Image crdit: hxxps://divoc.health/

DIVOC Health has received an import license from the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, for Genedrive 96 SARS-CoV-2 testing kits in India.



Following the approval, the diagnostic startup DIVOC health will be able to spot the active SARS-CoV-2 infection quickly and easily in COVID-19 patients with the help of this Genedrive 96 SARS-CoV-2 Kit designed by molecular diagnostics Genedrive located in the UK, that has received formal approval from the Indian Council of Medical Research (ICMR).



On receiving the approval, Dr Kanav Kahol, Founder and CEO, DIVOC health said, “We thank the diagnostic division of the Ministry of Health for considering our proposal and allowing us to deliver quality results to the consumers. At this time when the virus is rigorously spreading in the country, we understand that the availability of accurate and high-quality tests is critical to our fight against the pandemic, and hence, we identified the GeneDrive RT PCR COVID-19 tests as well suited to the Indian market due to its comparatively reduced processing steps, thermostability, and its high-quality manufacture.”



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients. It’s in a ready-to-go solid PCR bead format that eliminates the need for reagent preparation or cold temperature storage, which makes it a more suitable solution for high-temperature countries such as India. The format simplifies laboratory workflow, allowing a patient sample to be mixed with a single bead and then tested on a variety of third-party RT-PCR platforms.

[maxplus2] 25/6/2021 10:27

We're flying. Still not happy with BOD

[qs99] 25/6/2021 10:24

boom and may get an RNS before Monday at this rate IMO!

[robinyou] 25/6/2021 10:22

GDR

Get strapped in folks........The Market has just woken up to this news.
Try buying in any size now.DIVOC Health receives import license for covid testing kits from CDSCO
25 June 2021 | News



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients

Image crdit: hxxps://divoc.health/
Image crdit: hxxps://divoc.health/

DIVOC Health has received an import license from the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, for Genedrive 96 SARS-CoV-2 testing kits in India.



Following the approval, the diagnostic startup DIVOC health will be able to spot the active SARS-CoV-2 infection quickly and easily in COVID-19 patients with the help of this Genedrive 96 SARS-CoV-2 Kit designed by molecular diagnostics Genedrive located in the UK, that has received formal approval from the Indian Council of Medical Research (ICMR).



On receiving the approval, Dr Kanav Kahol, Founder and CEO, DIVOC health said, “We thank the diagnostic division of the Ministry of Health for considering our proposal and allowing us to deliver quality results to the consumers. At this time when the virus is rigorously spreading in the country, we understand that the availability of accurate and high-quality tests is critical to our fight against the pandemic, and hence, we identified the GeneDrive RT PCR COVID-19 tests as well suited to the Indian market due to its comparatively reduced processing steps, thermostability, and its high-quality manufacture.”



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients. It’s in a ready-to-go solid PCR bead format that eliminates the need for reagent preparation or cold temperature storage, which makes it a more suitable solution for high-temperature countries such as India. The format simplifies laboratory workflow, allowing a patient sample to be mixed with a single bead and then tested on a variety of third-party RT-PCR platform.

[swerves1] 25/6/2021 10:22

Great news. Could be an RNS on this...Mon 7am!

[robinyou] 25/6/2021 10:14

DIVOC Health receives import license for covid testing kits from CDSCO
25 June 2021 | News



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients

Image crdit: hxxps://divoc.health/
Image crdit: hxxps://divoc.health/

DIVOC Health has received an import license from the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, for Genedrive 96 SARS-CoV-2 testing kits in India.



Following the approval, the diagnostic startup DIVOC health will be able to spot the active SARS-CoV-2 infection quickly and easily in COVID-19 patients with the help of this Genedrive 96 SARS-CoV-2 Kit designed by molecular diagnostics Genedrive located in the UK, that has received formal approval from the Indian Council of Medical Research (ICMR).



On receiving the approval, Dr Kanav Kahol, Founder and CEO, DIVOC health said, “We thank the diagnostic division of the Ministry of Health for considering our proposal and allowing us to deliver quality results to the consumers. At this time when the virus is rigorously spreading in the country, we understand that the availability of accurate and high-quality tests is critical to our fight against the pandemic, and hence, we identified the GeneDrive RT PCR COVID-19 tests as well suited to the Indian market due to its comparatively reduced processing steps, thermostability, and its high-quality manufacture.”



The kit is a novel Polymerase Chain Reaction (PCR) assay that is designed to detect active SARS-CoV-2 infection in COVID-19 patients. It’s in a ready-to-go solid PCR bead format that eliminates the need for reagent preparation or cold temperature storage, which makes it a more suitable solution for high-temperature countries such as India. The format simplifies laboratory workflow, allowing a patient sample to be mixed with a single bead and then tested on a variety of third-party RT-PCR platforms.


Whooooosh......comes to mind when The Market catches on.

[peaky00] 25/6/2021 01:15

Peaky always said this was heading to 20p range when this was 1.50ish.... remember

[yasyas1] 24/6/2021 20:26

Tbh really pathetic performance from gdr. Waiting for aihl test. Given up on covid tests

[pal44] 24/6/2021 15:01

Not progress it's just demise mate time the BoD wake up and make some progress investors are waiting

[maxplus2] 24/6/2021 13:53

Even if the company is in close period, the progress have been slow. Just look at Avacta as like to like comparison. We still had no sales, no FDA etc.